The Role of Fecal Microbiota Transplant (FMT) in Treating C. difficile

A Podcast with Lawrence J. Brandt, MD, MACG

The American Journal of Gastroenterology (AJG) Co-Editor William D. Chey, MD, FACG, talks with Lawrence J. Brandt, MD, MACG, on the efficacy of this potentially lifesaving procedure and how the FDA’s recent classification of stool as a “drug” could impact physicians who want to use FMT as a treatment option for their patients. A leading pioneer in the use of fecal microbiota transplantation (FMT) in treating C. difficile infection, Dr. Brandt gave the 2012 AJG Lecture that was also published in the February issue. (33:10)

Read the Article

Download from iTunes

Listen to the Podcast